Innovative MedTech Inc. (IMTH)
USD 0.43
(0.0%)
USD 0.43
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 1.82 Million USD | 5.8% |
| 2023 | 1.72 Million USD | 32.92% |
| 2022 | 1.29 Million USD | 271.66% |
| 2021 | 349.14 Thousand USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 668.37 Thousand USD | 3.62% |
| 2010 | 645.03 Thousand USD | 637.16% |
| 2009 | 87.5 Thousand USD | -64.95% |
| 2008 | 249.63 Thousand USD | -15.66% |
| 2007 | 296 Thousand USD | 66.7% |
| 2006 | 177.56 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 456.36 Thousand USD | 0.26% |
| 2024 Q3 | 455.16 Thousand USD | 5.19% |
| 2024 Q2 | 432.69 Thousand USD | -9.99% |
| 2024 Q1 | 480.7 Thousand USD | 8.46% |
| 2023 Q2 | 420.35 Thousand USD | 9.42% |
| 2023 Q1 | 384.15 Thousand USD | 7.14% |
| 2023 FY | 1.72 Million USD | 32.92% |
| 2023 Q4 | 443.22 Thousand USD | -7.1% |
| 2023 Q3 | 477.11 Thousand USD | 13.5% |
| 2022 FY | 1.29 Million USD | 271.66% |
| 2022 Q4 | 358.55 Thousand USD | 22.88% |
| 2022 Q3 | 291.78 Thousand USD | -11.77% |
| 2022 Q2 | 330.7 Thousand USD | 4.47% |
| 2022 Q1 | 316.56 Thousand USD | 13.9% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q4 | 277.94 Thousand USD | 290.36% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q3 | 71.2 Thousand USD | 0.0% |
| 2021 FY | 349.14 Thousand USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q1 | -422.16 Thousand USD | -554.23% |
| 2013 Q2 | - USD | 100.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 Q2 | 139.23 Thousand USD | -15.77% |
| 2012 FY | - USD | -100.0% |
| 2012 Q4 | 92.94 Thousand USD | -51.08% |
| 2012 Q3 | 189.98 Thousand USD | 36.45% |
| 2012 Q1 | 165.31 Thousand USD | 64.76% |
| 2011 Q1 | 181.94 Thousand USD | -35.58% |
| 2011 FY | 668.37 Thousand USD | 3.62% |
| 2011 Q4 | 100.33 Thousand USD | -54.73% |
| 2011 Q3 | 221.64 Thousand USD | 22.4% |
| 2011 Q2 | 181.08 Thousand USD | -0.47% |
| 2010 FY | 645.03 Thousand USD | 637.16% |
| 2010 Q1 | 20.23 Thousand USD | 5.9% |
| 2010 Q2 | 17.88 Thousand USD | -11.59% |
| 2010 Q3 | 170.8 Thousand USD | 854.8% |
| 2010 Q4 | 282.42 Thousand USD | 65.35% |
| 2009 Q1 | 56.44 Thousand USD | -1.6% |
| 2009 Q4 | 19.1 Thousand USD | 154.03% |
| 2009 Q3 | 7522.00 USD | -81.49% |
| 2009 Q2 | 40.63 Thousand USD | -28.01% |
| 2009 FY | 87.5 Thousand USD | -64.95% |
| 2008 Q2 | 68.19 Thousand USD | -13.3% |
| 2008 Q1 | 78.64 Thousand USD | -38.75% |
| 2008 Q3 | 67.63 Thousand USD | -0.81% |
| 2008 Q4 | 57.36 Thousand USD | -15.19% |
| 2008 FY | 249.63 Thousand USD | -15.66% |
| 2007 Q3 | 63.94 Thousand USD | 155.76% |
| 2007 Q4 | 128.41 Thousand USD | 100.81% |
| 2007 FY | 296 Thousand USD | 66.7% |
| 2007 Q1 | 129.04 Thousand USD | 165.92% |
| 2007 Q2 | 25 Thousand USD | -80.62% |
| 2006 Q3 | 69.00 USD | -8.0% |
| 2006 Q2 | 75.00 USD | 0.0% |
| 2006 Q4 | 48.52 Thousand USD | 70227.54% |
| 2006 FY | 177.56 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | 42.819% |
| Ansell Limited | 1.61 Billion USD | 99.887% |
| Ansell Limited | 1.61 Billion USD | 99.887% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | 99.012% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -1251.246% |
| Psykey, Inc. | 419.29 Thousand USD | -335.232% |
| ConvaTec Group Plc | 2.19 Billion USD | 99.917% |
| ConvaTec Group Plc | 2.14 Billion USD | 99.915% |
| Encision Inc. | 6.58 Million USD | 72.29% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| LifePoint, Inc. | -18.5 Thousand USD | 9964.459% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | 73.214% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -136.389% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -85.042% |
| Reflect Scientific, Inc. | 1.08 Million USD | -68.95% |
| SmileDirectClub, Inc. | 470.74 Million USD | 99.612% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 99.902% |
| SheerVision, Inc. | 3.49 Million USD | 47.85% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -31.641% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -144.926% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -1649.974% |